May 23, 2025

NCCN Clinical Practice Guidelines in Oncology: 2025 Updates

The National Comprehensive Cancer Network (NCCN) released its first set of Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in 1996, covering eight tumor types. Today, guidelines are availa...

The ASCO Post

May 22, 2025

Cardiogenic Shock in Women: Treatment Disparities Persist

New expert consensus statement reveals that women with cardiogenic shock face significant treatment disparities and outlines evidence-based recommendations for improving outcomes.

Conexiant

April 28, 2025

ADA invites dental schools to become testing sites for potential Seal products

The ADA Qualified Sites program connects manufacturers with research sites that are qualified to test their products for the Seal program.

ADA News

June 12, 2024

USPSTF Releases Draft Osteoporosis Screening Guidelines

The USPSTF's draft recommendations reaffirm osteoporosis screening for older women, call for more research on screening men, and address health disparities.

Conexiant

January 14, 2025

Does Screening Cut Hip Fracture Risks?

"Screening in higher-risk women 65 years or older was associated with a small absolute risk reduction in hip and major fractures compared with usual care."

Conexiant

May 24, 2024

Senate committee holds hearing on dental affordability and availability

A Senate committee discussed various ways to make oral health care more accessible and affordable for Americans, including.

ADA News

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant

August 09, 2024

Updated Guidance on Contraceptive Use

The CDC has released updated contraceptive guidance for health care providers, emphasizing patient autonomy and evidence-based recommendations to support high-quality, equitable contraceptive care.

Conexiant

July 01, 2024

FDA Clears AI Device for Portable Diabetic Retinopathy Screening

AEYE Health announced that it has received the first FDA clearance for a fully autonomous AI system that diagnoses referable diabetic retinopathy (DR) from retinal images captured by a handheld camera.

Retinal Physician